The Revised Who Classification of Myeloproliferative Neoplasms – What Has Changed?

Pathology - United States
doi 10.1016/j.pathol.2020.01.144
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Revised Who Classification of Myelodysplastic Syndromes – What Has Changed?

Pathology
Forensic MedicinePathology
2020English

New Classification for Myeloproliferative Neoplasms

Cancer Discovery
Oncology
2018English

Impact of the 2016 Revised WHO Criteria for Myeloproliferative Neoplasms, Unclassifiable: Comparison With the 2008 Version

American Journal of Hematology
Hematology
2017English

Erratum To: Rheumatoid Arthritis: What Has Changed?

Skeletal Radiology
Nuclear MedicineRadiologyImaging
2010English

A Revised 4 Edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: Myeloid Neoplasms

Arkhiv Patologii
Forensic MedicinePathology
2018English

Fuelwood Revisited: What Has Changed in the Last Decade?

2003English

What Has Changed in the Structure of Revision Hip Arthroplasty?

Traumatology and Orthopedics of Russia
2019English

Autoimmune Encephalitis: What Has Changed During the Past 15 Years?

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2019English

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy